EPO Patents = 3

Forward Citations = 24

Loading Chart...

12 inventors (with patents filed for the assignee):

Yuanjun He (7 out of 12 patents)

Theodore M Kamenecka (7 out of 26 patents)

Qin Jiang (3 out of 15 patents)

4. Robert Jason Herr (3 out of 19 patents)

5. Steven Sigmund Wesolowski (3 out of 10 patents)

6. William Nguyen (3 out of 3 patents)

7. Rong Jiang (3 out of 5 patents)

8. Xinyi Song (3 out of 5 patents)

9. Roland W Bürli (2 out of 18 patents)

10. Jörg Holenz (2 out of 7 patents)

11. Jörg Holenz (1 out of 1 patent)

12. Roland Bürli (1 out of 1 patent)

13. Roland BÜRLI (0 patent)

7 patents: Sort by Forward Citations

1. 12084437 - Halo-substituted piperidines as orexin receptor modulators (2024-09-10),

2. 11434236 - Halo-substituted piperidines as orexin receptor modulators (2022-09-06),

3. 10894789 - Halo-substituted piperidines as orexin receptor modulators (2021-01-19),

4. 10221170 - Difluoropyrrolidines as orexin receptor modulators (2019-03-05),

5. 9896452 - Substituted prolines/piperidines as orexin receptor antagonists (2018-02-20),

6. 9499517 - Substituted prolines / piperidines as orexin receptor antagonists (2016-11-22),

7. 9440982 - Substituted prolines/piperidines as orexin receptor antagonists (2016-09-13),

Eolas Therapeutics is a biopharmaceutical company specializing in the development of innovative therapies for neurodegenerative disorders. Our focus is on discovering and advancing novel treatments that have the potential to improve the lives of patients suffering from diseases such as Alzheimer's, Parkinson's, and multiple sclerosis.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#148 in Carlsbad, CA

#9,216 in California

#38,834 in US

Carlsbad, CA, United States of America

Eolas Therapeutics, Inc.